The impact of pneumococcal vaccination and nasopharyngeal colonization on the performance of a serotype-specific urine antigen detection (SSUAD) assay.

Saved in:
Bibliographic Details
Title: The impact of pneumococcal vaccination and nasopharyngeal colonization on the performance of a serotype-specific urine antigen detection (SSUAD) assay.
Authors: Cheon K; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: kyeongmi.cheon@merck.com., Buchwald UK; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: ulrike.buchwald@merck.com., Hammitt LL; Johns Hopkins Bloomberg School of Public Health, International Health, Baltimore, MD, USA. Electronic address: lhammitt@jhu.edu., LeBlanc JJ; Division of Microbiology, Department of Pathology and Laboratory Medicine, Nova Scotia Health, Halifax, Nova Scotia, Canada; Department of Pathology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: Jason.Leblanc@nshealth.ca., Tso C; Johns Hopkins Bloomberg School of Public Health, International Health, Baltimore, MD, USA. Electronic address: ctso1@jhu.edu., Riley DP; Johns Hopkins Bloomberg School of Public Health, International Health, Baltimore, MD, USA. Electronic address: dparke71@jhu.edu., VanDeRiet D; Johns Hopkins Bloomberg School of Public Health, International Health, Baltimore, MD, USA. Electronic address: dvander4@jhu.edu., Weatherholtz R; Johns Hopkins Bloomberg School of Public Health, International Health, Baltimore, MD, USA. Electronic address: rweathe1@jhu.edu., Musey L; Merck & Co., Inc., Rahway, NJ, USA., Shekar T; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: tulin.shekar@merck.com., Cooper S; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: stephanie.cooper@merck.com., Patel R; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: roshni.patel@merck.com., Chamcha R; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: radha.chamcha@merck.com., Cronk J; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: justin.cronk@merck.com., Rajam G; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: gowrisankar.rajam@merck.com., Fu W; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: wei.fu3@merck.com., Nolan KM; Merck & Co., Inc., Rahway, NJ, USA. Electronic address: katrina.nolan@merck.com.
Source: Vaccine [Vaccine] 2025 Aug 30; Vol. 62, pp. 127453. Date of Electronic Publication: 2025 Aug 30.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2025.127453